| Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury | |
| Tu, Chuan-Tao; Guo, Jin-Sheng; Wang, Manner; Wang, Ji-Yao | |
| 刊名 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
 |
| 2007 | |
| 卷号 | 22期号:6 |
| 关键词 | cyclooxygenase-2 liver fibrosis portal hypertension rofecoxib |
| ISSN号 | 0815-9319 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4961308 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Tu, Chuan-Tao,Guo, Jin-Sheng,Wang, Manner,et al. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,2007,22(6). |
| APA | Tu, Chuan-Tao,Guo, Jin-Sheng,Wang, Manner,&Wang, Ji-Yao.(2007).Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,22(6). |
| MLA | Tu, Chuan-Tao,et al."Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury".JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 22.6(2007). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论